Biostar Pharmaceuticals (BSPM)
(Delayed Data from OTC)
$0.00 USD
-0.01 (-98.95%)
Updated Dec 27, 2023 03:20 PM ET
NA Value
NA Growth NA Momentum NA VGMCompany Summary
BioStar Pharmaceuticals, Inc., through its wholly-owned subsidiary, Shaanxi Aoxing Pharmaceutical Co., Ltd., develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based over-the-counter products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents. It also operates an herbal medicine planting base which provides it with many of its needed materials at a significantly lower cost than purchasing from third parties, and eliminates most needs for transportation.
Company Summary
General Information
Biostar Pharmaceuticals, Inc
NO. 588 SHIJI XI AVENUE
XIANYANG, F4 712046
Phone: 011-86-29-3368-6638
Fax: NA
Web: http://www.biostarpharmaceuticals.com
Email: NA
Industry | Medical - Drugs |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 12/31/2023 |
Exp Earnings Date | NA |
EPS Information
Current Quarter EPS Consensus Estimate | NA |
Current Year EPS Consensus Estimate | NA |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | NA |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 0.00 |
52 Week High | 0.01 |
52 Week Low | 0.00 |
Beta | NA |
20 Day Moving Average | 0.00 |
Target Price Consensus | 0.00 |
4 Week | NA |
12 Week | NA |
YTD | NA |
4 Week | NA |
12 Week | NA |
YTD | NA |
Shares Outstanding (millions) | NA |
Market Capitalization (millions) | NA |
Short Ratio | NA |
Last Split Date | 2/5/2016 |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | NA |
Change in Payout Ratio | NA |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | NA |
Trailing 12 Months | NA |
PEG Ratio | NA |
vs. Previous Year | NA |
vs. Previous Quarter | NA |
vs. Previous Year | NA% |
vs. Previous Quarter | NA% |
Price/Book | NA |
Price/Cash Flow | NA |
Price / Sales | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |
12/31/23 | NA |
9/30/23 | NA |
6/30/23 | NA |